Biochemical analysis of the hippocampus showed that AAV-NF-α1/CPE treatment prevented hyperphosphorylation of tau at specific residues, Ser396, Ser202 and Thr205, known to be involved in AD [47–50]. The gene discussed is MAPT; the disease is Alzheimer disease.